Patents Examined by Elizabeth K So
  • Patent number: 9913973
    Abstract: The present invention generally relates to the use of electrodes with human and animal subjects. More particularly, the present invention relates to electrical contacts which are applied to the surface of a subject for the purpose of delivering transranial direct current stimulation (TDCS).
    Type: Grant
    Filed: April 23, 2013
    Date of Patent: March 13, 2018
    Assignee: Yani Skincare, LLC
    Inventor: Jamal S. Yanaki
  • Patent number: 9895100
    Abstract: The present disclosure provides a wearable device for the detection of mild traumatic brain injury, such as concussions, and methods of use thereof. Further disclosed are a method and system for detecting a mild traumatic brain injury.
    Type: Grant
    Filed: October 3, 2014
    Date of Patent: February 20, 2018
    Assignee: Indiana University Research and Technology Corporation
    Inventor: Nicholas L. Port
  • Patent number: 9878171
    Abstract: A system including an ambulatory medical treatment device is provided. The ambulatory medical treatment device includes a memory, a treatment component configured to treat a patient, at least one processor coupled to the memory and the treatment component, a user interface component, and a system interface component. The user interface component is configured to receive an update session request and to generate the update session identifier responsive to receiving the request. The system interface component is configured to receive an encoded request including an identifier of an update session and device update information, to decode the encoded request to generate a decoded request including the device update information and the identifier of the update session, to validate the decoded request by determining that the update session identifier matches the identifier of the update session, and to apply the device update information to the ambulatory medical treatment device.
    Type: Grant
    Filed: March 1, 2013
    Date of Patent: January 30, 2018
    Assignee: ZOLL Medical Corporation
    Inventor: Thomas E. Kaib
  • Patent number: 9844404
    Abstract: An electrosurgical system for performing an electrosurgical procedure is provided and includes an electrosurgical generator and a calibration computer system. The electrosurgical generator includes one or more processors and a measurement module including one or more log amps that are in operative communication with the processor. The calibration computer system configured to couple to a measurement device and is configured to measure parameters of an output signal generated by the electrosurgical generator. The calibration computer system is configured to compile the measured parameters into one or more data look-up tables and couple to the electrosurgical generator for transferring the data look-up table(s) to memory of the electrosurgical generator. The microprocessor is configured to receive an output from the log amp(s) and access the data look-up table(s) from memory to execute one or more control algorithms for controlling an output of the electrosurgical generator.
    Type: Grant
    Filed: July 24, 2015
    Date of Patent: December 19, 2017
    Assignee: COVIDIEN LP
    Inventors: Robert J. Behnke, II, Donald W. Heckel, Robert B. Smith, James E. Krapohl
  • Patent number: 9844661
    Abstract: In one embodiment, a neurostimulation lead for stimulating neural tissue of a patient, comprises: a lead body of insulative material; a plurality of electrodes; a plurality of terminals; a plurality of conductors, wherein the plurality of electrodes are electrically coupled to the plurality of terminals through the plurality of conductors; wherein the plurality of conductors are disposed in a helical manner in a repeating pattern of groups of conductors separated by gaps along a substantial length of the lead body, each gap being larger than an inter-conductor pitch within the groups of conductors; wherein the insulative material is a compliant material permitting elongation of the lead at low stretching forces and the insulative material of the lead body is fused through a substantial volume of the lead body and along a substantial length of the lead body.
    Type: Grant
    Filed: January 18, 2012
    Date of Patent: December 19, 2017
    Assignee: Advanced Neuromodulation Systems Inc.
    Inventors: Brian Franz, John Swanson, Jerome Boogaard, Terry D. Daglow, Tom Sosebee, Stephen L. Goldman, Rajasree (Sarah) Das, Michael DiGiacomo
  • Patent number: 9833610
    Abstract: A lead assembly includes an implantable lead. Electrodes are disposed along a distal end of the lead in an electrode array. Terminals are disposed along a proximal end of the lead in a proximal-most terminal array and a medial terminal array. A terminal extension electrically couples to the medial terminal array. A port is defined in a connector at a first end of the terminal extension. The port has a first end and an opposing second end and forms a continuous passageway therebetween. The port receives the medial terminal array. A contact array includes connector contacts that are disposed within the port and that couple electrically with a terminal array disposed along a second end of the terminal extension. The contact array couples electrically with terminals of the medial terminal array of the lead when the medial terminal array is received by the port.
    Type: Grant
    Filed: March 8, 2016
    Date of Patent: December 5, 2017
    Assignee: Boston Scientific Neuromodulation Corporation
    Inventors: Matthew Lee McDonald, Jacob Matthew Muhleman, Rafael Carbunaru
  • Patent number: 9827421
    Abstract: An exemplary method of treating a chronic low back pain condition in a patient includes 1) generating, by an electroacupuncture device implanted beneath a skin surface of the patient at at least one of acupoints BL22, BL23, BL24, BL25, and BL26 within the patient, stimulation sessions at a duty cycle that is less than 0.05, wherein the duty cycle is a ratio of T3 to T4 and each stimulation session included in the stimulation sessions has a duration of T3 minutes and occurs at a rate of once every T4 minutes, and 2) applying, by the electroacupuncture device, the stimulation sessions to the target tissue location in accordance with the duty cycle.
    Type: Grant
    Filed: July 28, 2015
    Date of Patent: November 28, 2017
    Assignee: Valencia Technologies Corporation
    Inventors: Jeffrey H. Greiner, David K. L. Peterson, Chuladatta Thenuwara, Stacy Greiner Chambliss
  • Patent number: 9827134
    Abstract: An implantable electroacupuncture device (IEAD) treats an erectile dysfunction condition of a patient through application of stimulation pulses applied at a target tissue location underlying, or in the vicinity of, at least one of acupoints BL52, BL23 or GV4. The IEAD includes an IEAD housing having an electrode configuration thereon that includes at least two electrodes, and pulse generation circuitry located within the IEAD housing and electrically coupled to the at least two electrodes. The pulse generation circuitry is adapted to deliver EA stimulation pulses to the patient's body tissue at or near the target tissue location in accordance with a specified stimulation regimen, the stimulation regimen requiring that the stimulation session have a duration of T3 minutes and a rate of occurrence of once every T4 minutes, and wherein a ratio of T3/T4 is no greater than 0.05.
    Type: Grant
    Filed: July 14, 2015
    Date of Patent: November 28, 2017
    Assignee: Valencia Technologies Corporation
    Inventors: Jeffrey H. Greiner, David K. L. Peterson, Chuladatta Thenuwara, Stacy Greiner Chambliss
  • Patent number: 9827037
    Abstract: A tissue cutting device has an outer sleeve with a distal window and an inner cutting sleeve which moves past the window to cut tissue. The inner cutting sleeve has a lumen which may have a larger proximal diameter than distal diameter. A perimeter of the window may comprise a dielectric material. A distal edge of the inner sleeve may be displaced inwardly.
    Type: Grant
    Filed: December 29, 2015
    Date of Patent: November 28, 2017
    Assignee: BOSTON SCIENTIFIC SCIMED, INC.
    Inventors: Aaron Germain, Kyle Klein, Michael D. Walker, Benedek Orczy-Timko, Balazs Lesko
  • Patent number: 9814888
    Abstract: Systems and methods for optimizing the stimulation of a heart of a patient are disclosed herein. The method comprises delivering pacing therapy to the patient according to a pacing therapy setting schedule, using specific pacing intervals via specific electrode configurations. Further, sinus rate values are recorded over at least one cardiac cycle at each pacing therapy setting and it is determined whether a sinus rate value satisfies predetermined measurement conditions, wherein sinus rate values are used for trending the sinus rate over time if the measurement conditions are satisfied. The accepted sinus rate values, i.e. values that satisfy the measurement conditions, are trended over time, wherein each trended sinus rate value is created based on recordings from at least one cardiac cycle. A preferred pacing therapy setting is determined to be the pacing therapy setting that provides a lowest sinus rate.
    Type: Grant
    Filed: August 18, 2015
    Date of Patent: November 14, 2017
    Assignee: St. Jude Medical, AB
    Inventors: Nils Holmstrom, Andreas Karlsson
  • Patent number: 9808619
    Abstract: Electrotherapy systems and methods for delivering an electrostimulation treatment program to a user while reducing the risk of inducing cardiac fibrillation. The systems and methods detect electrostimulation treatment program delivery characteristics, including a pulse intensity above a preset limit; a pulse duration above a preset limit; an inappropriately compensated pulse; a charge per pulse above a predetermined limit; a current improperly exiting from a stimulation channel; a current present outside of a pulse; an excitation pulse and a compensation pulse generated on different channels; an inter-pulse time less than a predetermined limit; and a time between an excitation and a compensation pulse greater than a predetermined limit. The limits are selected in relation to an objective of reducing the risk of inducing cardiac fibrillation.
    Type: Grant
    Filed: February 10, 2012
    Date of Patent: November 7, 2017
    Assignee: Encore Medical Asset Corporation
    Inventors: Felix Buhlmann, Etienne Dunant, Steve Guex, David Truffer, Pierre-Yves Mueller
  • Patent number: 9808163
    Abstract: A method and apparatus for monitoring heart rate. The method includes receiving a digital heart monitoring signal, determining the integrity of said signal with a “hand detect” signal that confirms electrical connection to the subject, dividing the digital heart monitoring signal into at least one frame, generating a folded correlation value for the center sample in the at least one frame, identify the number of peaks folded correlation values based on amplitude and distance parameters of the digital heart monitoring signal in the at least one frame, removing false peaks and collecting peaks corresponding to a length of time, determining the heart rate based on the identified peaks wherein the identified peaks relate to a minimum distance between valid heart beat peaks based on a heart rate estimate, computing the weighted average of heart rate value based on the number of previous heart rate values.
    Type: Grant
    Filed: April 27, 2010
    Date of Patent: November 7, 2017
    Assignee: TEXAS INSTRUMENTS INCORPORATED
    Inventors: Steven T. Dunbar, Sourabh Ravindran
  • Patent number: 9808168
    Abstract: A method and system are presented for use in assessment of at least one cardiac parameter of an individual. An electrodes arrangement is applied to an individual's body, for applying an electrical field to the body and providing an electrical output indicative of a systolic impedance change and of a velocity of said change during a cardiac cycle. Also provided is additional data indicative of at least of the following conditions of the individual: a value of total peripheral resistance (TPR), a value of cardiac index (CI), and existence of the AHF condition.
    Type: Grant
    Filed: November 17, 2014
    Date of Patent: November 7, 2017
    Assignee: New N.I. Medical (2011) LTD.
    Inventors: Daniel A. Goor, Efim Frinerman, Evgeny Granov, Igor Granov
  • Patent number: 9792408
    Abstract: The presence or absence of objects tagged with transponders may be determined in an environment in which medical procedures are performed via an interrogation and detection system which includes a controller and a plurality of antennas positioned along a patient support structure. The antennas may be positioned along an operating table, bed, mattress or pad, sheet, or may be positioned on a drape, or shade. Respective antennas may successively be activated to transmit interrogation signals. Multiple antennas may be monitored for responses from transponders to the interrogation signals. For example, all antennas other than the antenna that transmitted the most recent interrogation signal may be monitored. Antennas may be responsive to force, a signal indicative of such force being produced. A wireless physiological condition monitor may detect patient physiological conditions and wirelessly transmit signals indicative of such.
    Type: Grant
    Filed: October 27, 2009
    Date of Patent: October 17, 2017
    Assignee: Covidien LP
    Inventors: William A. Blair, Bruce E. Barnes, David A. Poirier
  • Patent number: 9788882
    Abstract: An electrosurgical wand. At least some of the illustrative embodiments are electrosurgical wands configured as a surgical forceps including opposed legs that defines respective distal end portions, the legs of the forceps operable to be actuated between an open position and a closed position, an active and return electrode disposed on one of the respective distal end portions, a discharge aperture on one of the distal end portions coupled to a first fluid conduit, and an aspiration aperture through the return electrode on the other of the distal end portions fluidly coupled to a second fluid conduit. In embodiments, the position of the forceps' legs, and the electrical energy applied to the electrodes, is adjusted to provide dissection or coagulation to the tissue. A stop or latch on the forceps' legs may maintain the active and return electrode a fixed distance from one another.
    Type: Grant
    Filed: September 10, 2012
    Date of Patent: October 17, 2017
    Assignee: ArthroCare Corporation
    Inventors: Doug Evans, Lloyd Gonzalez, Nathan Wang, Jean Woloszko
  • Patent number: 9770585
    Abstract: A retractable screw-type stimulation or defibrillation intracardiac lead is disclosed. According to one embodiment, the lead comprises a flexible hollow sheath (12) having at its distal end a lead head (10) and a connector (66) at its proximal end. The connector comprises a pin (62) connected to a lead head electrode (18). The lead head comprises a tubular body (28), at least one electrode (18, 20) for stimulation or defibrillation, a moving element translationally and rotationally moving within the tubular body in a helical motion, and an anchoring screw (24) axially moving with respect to the tubular body, and a deployment mechanism (22) to deploy the anchoring screw out of the tubular body (28).
    Type: Grant
    Filed: May 18, 2015
    Date of Patent: September 26, 2017
    Assignee: SORIN CRM SAS
    Inventor: Jean-François Ollivier
  • Patent number: 9750932
    Abstract: The disclosure describes systems, methods, and apparatus providing detection mechanism for lead-related conditions, including transient behaviors, on a conductive pathway of a medical electrical lead. In one example, a sense path arbitration module identifies a lead-related condition associated with a conductive pathway based on signal processing to identify transients emerging from a propagated signal. The sense path arbitration module may evaluate a plurality of conductive pathways of the medical electrical lead and arbitrates propagation of a sensed signal that is transmitted through the plurality of lead conductors based on the evaluation. Therapy delivery functions utilizing the medical electrical lead may also be controlled in response to the signal processing and identification of the lead-related condition on a conductive pathway.
    Type: Grant
    Filed: January 11, 2016
    Date of Patent: September 5, 2017
    Assignee: Medtronic, Inc.
    Inventors: Thomas H Spear, Nancy M Germanson
  • Patent number: 9744356
    Abstract: Techniques for automatically analyzing neural activity within a target neural region. In one example, electrical stimulation is applied to the target neural region at an initial current level that approximates a typical threshold-Neural Response Telemetry (NRT) level. An NRT measurement of neural activity within the target neural region in response to the stimulation is recorded. A machine-learned expert system, which is configured with a decision tree that includes at least two levels of nodes which consider parameters relating to the NRT measurement, respectively, is utilized to predict, based on one or more features of the neural activity, whether the NRT measurement includes a neural response or does not include a neural response.
    Type: Grant
    Filed: January 6, 2015
    Date of Patent: August 29, 2017
    Assignee: Cochlear Limited
    Inventors: Andrew Botros, Matthijs Killian, Bastiaan van Dijk
  • Patent number: 9744348
    Abstract: Embodiments of the invention are related to leads with topographic surface features and related methods, amongst other things. In an embodiment, the invention includes an implantable lead including a lead body having a proximal end and a distal end, the lead body including an outer layer defining a lumen, the lead body further including a first electrical conductor disposed within the lumen of the outer layer. The implantable lead can further include a first electrode coupled to the lead body, the electrode in electrical communication with the first electrical conductor. The implantable lead can also include a cellular modulation segment on the external surface of the lead body, the cellular modulation segment comprising topographic surface features configured to modulate cellular responses. Other embodiments are also included herein.
    Type: Grant
    Filed: August 21, 2007
    Date of Patent: August 29, 2017
    Assignee: CARDIAC PACEMAKERS, INC.
    Inventors: Craig M. Stolen, Mark J. Schwartz, John D. Foley, Lili Liu
  • Patent number: 9731119
    Abstract: An implantable medical device (IMD) can include a cardiac pacemaker or an implantable cardioverter-defibrillator (ICD). Various portions of the IMD, such as a device body, a lead body, or a lead tip, can be provided to reduce or dissipate a current and heat induced by various external environmental factors. According to various embodiments, features can be incorporated into the lead body, the lead tip, or the IMD body to reduce the creation of an induced current, or dissipate the induced current and heat created due to an induced current in the lead. For example, an IMD can include at least one outer conductive member and a first electrode. The first electrode can be in electrical communication with the at least one outer conductive member. The first electrode can dissipate a current induced in the at least one outer conductive member via a first portion of the anatomical structure.
    Type: Grant
    Filed: May 18, 2015
    Date of Patent: August 15, 2017
    Assignee: MEDTRONIC, INC.
    Inventor: Mark T. Marshall